Loading
AI
Apexigen, Inc. Stock: price and insider trades · United States
Apexigen, Inc.: what insiders have been doing
Apexigen, Inc. is a listed company. Its directors and officers file their transactions with SEC (Form 4). No insider at Apexigen, Inc. has published a filing in the past twelve months. The most recent one dates from 25 August 2023.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
26
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
3 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Last declaration on 25 August 2023
Declarations26 total
31,123 shares@ US$0.385152.5% of flowCommon StockSEC:0001209191-23-047439:0
26,416 shares@ US$0.385159.1% of flowCommon StockSEC:0001209191-23-047432:0
400,000 shares0Common StockSEC:0001209191-23-047429:0
10,000 sharesCommon StockSEC:0001209191-23-047450:0
146,383 sharesCommon StockSEC:0001209191-23-047454:0
16,354 sharesCommon StockSEC:0001209191-23-047436:0
4,504 shares@ US$0.491112.7% of flowCommon StockSEC:0001209191-23-039489:0
4,323 shares@ US$0.491131.1% of flowCommon StockSEC:0001209191-23-039492:0
7,001 shares@ US$0.491131.1% of flowCommon StockSEC:0001209191-23-039499:0
6,917 shares@ US$0.491114.8% of flowCommon StockSEC:0001209191-23-039495:0
150,000 shares0Common StockSEC:0001209191-23-032167:0
150,000 shares0Common StockSEC:0001209191-23-032162:0
146,383 shares0Common StockSEC:0001209191-23-031779:0
4,503 shares@ US$1.0628.2% of flowCommon StockSEC:0001209191-22-061975:0
4,323 shares@ US$1.0668.9% of flowCommon StockSEC:0001209191-22-062002:0
7,001 shares@ US$1.0668.9% of flowCommon StockSEC:0001209191-22-061966:0
6,916 shares@ US$1.0632.7% of flowCommon StockSEC:0001209191-22-062004:0
40,000 shares0Common StockSEC:0001209191-22-053349:0
30,685 shares0Common StockSEC:0001209191-22-053342:0
25,000 shares0Common StockSEC:0001209191-22-053346:0
25 of 26 declarations
About Apexigen, Inc.
Apexigen, Inc. is a biopharmaceutical company focused on developing immuno-oncology treatments. It utilizes its drug discovery platform to create therapeutic antibodies targeting tumors.
